OCT 01, 2015 7:30 AM PDT

Latest clinical results in oncology drug management

Speaker

Abstract

While TDM is routinely used in a number of medical fields, it has not gained wide utilization in oncology. There is a growing body of evidence demonstrating that current dosing methods based upon body surface area (BSA) are inadequate in delivering the proper drug exposure for optimal treatment effectiveness. BSA-based dosing is associated with drug plasma level variability as high as 30-fold and evidence exists that such inter- and intrapatient pharmacokinetic variability is a major contributor to toxicity and treatment failure. The use of therapeutic drug management (TDM) in oncology will not only serve to lower toxicity and improve efficacy but also help to control the escalating cost of cancer care. A recent randomized study with paclitaxel and carboplatin in NSCLC demonstrated that TDM led to lower dose intensity and significantly lower neuropathy without affecting efficacy. In another study with 5-fluorouricil (5-FU) in colorectal cancer the use TDM resulted in a majority of patients receiving higher exposure without increasing severe toxicities.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
JAN 21, 2021 8:00 AM PST
JAN 21, 2021 8:00 AM PST
Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
OCT 01, 2015 7:30 AM PDT

Latest clinical results in oncology drug management


Specialty

Clinical Diagnostics

Biomarkers

Antibodies

Virology

Laboratory Testing

Immunology

Dna Sequencing

Personalized Medicine

Immunity

Cancer Diagnostics

Immunotherapy

Bioinformatics

Flow Cytometry

Immuno-Oncology

Gene Expression

Geography

Europe100%

Registration Source

Website Visitors100%

Job Title

Student50%

Executive50%

Organization

Academic Institution50%

Independent Laboratories50%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more